Talk:Insulin glulisine
 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Insulin glulisine.
|
WikiProject class rating
This article was automatically assessed because at least one WikiProject had rated the article as start, and the rating on other projects was brought up to start class. BetacommandBot 16:28, 10 November 2007 (UTC)
Insulin glulisine has the similar advantages to other insulin analogues over ordinary insulin including: Better control of meal-time glycaemia, lower incidence of postprandial hypoglycaemia & greater reducing in HbA1c (use for assessment of diabetes mellitus treatment) than regular insulin —Preceding unsigned comment added by 41.236.235.48 (talk) 14:34, 6 May 2010 (UTC)
really need an expert?
The topic is marked as needing an expert in pharmacology. While this would be ideal, the main issue is that the article is only a stub. A knowledgeable non-expert could improve it greatly. (I could do it but unfortunately I don't have time.) Paleolith (talk) 20:53, 16 September 2012 (UTC)